Optical endomicroscopy and the road to real-time, in vivo pathology: present and future
© Carignan and Yagi; licensee BioMed Central Ltd. 2012
Received: 25 April 2012
Accepted: 19 July 2012
Published: 13 August 2012
Epithelial cancers account for substantial mortality and are an important public health concern. With the need for earlier detection and treatment of these malignancies, the ability to accurately detect precancerous lesions has an increasingly important role in controlling cancer incidence and mortality. New optical technologies are capable of identifying early pathology in tissues or organs in which cancer is known to develop through stages of dysplasia, including the esophagus, colon, pancreas, liver, bladder, and cervix. These diagnostic imaging advances, together as a field known as optical endomicroscopy, are based on confocal microscopy, spectroscopy-based imaging, and optical coherence tomography (OCT), and function as “optical biopsies,” enabling tissue pathology to be imaged in situ and in real time without the need to excise and process specimens as in conventional biopsy and histopathology. Optical biopsy techniques can acquire high-resolution, cross-sectional images of tissue structure on the micron scale through the use of endoscopes, catheters, laparoscopes, and needles. Since the inception of these technologies, dramatic technological advances in accuracy, speed, and functionality have been realized. The current paradigm of optical biopsy, or single-area, point-based images, is slowly shifting to more comprehensive microscopy of larger tracts of mucosa. With the development of Fourier-domain OCT, also known as optical frequency domain imaging or, more recently, volumetric laser endomicroscopy, comprehensive surveillance of the entire distal esophagus is now achievable at speeds that were not possible with conventional OCT technologies. Optical diagnostic technologies are emerging as clinically useful tools with the potential to set a new standard for real-time diagnosis. New imaging techniques enable visualization of high-resolution, cross-sectional images and offer the opportunity to guide biopsy, allowing maximal diagnostic yields and appropriate staging without the limitations and risks inherent with current random biopsy protocols. However, the ability of these techniques to achieve widespread adoption in clinical practice depends on future research designed to improve accuracy and allow real-time data transmission and storage, thereby linking pathology to the treating physician. These imaging advances are expected to eventually offer a see-and-treat paradigm, leading to improved patient care and potential cost reduction.
The virtual slide(s) for this article can be found here:http://www.diagnosticpathology.diagnomx.eu/vs/5372548637202968
KeywordsBarrett’s esophagus Cancer Confocal microscopy Dysplasia Endoscopy In vivo imaging Neoplasia Optical coherence tomography Optical imaging
Cancers affecting the mucosal tracts are a substantial public health concern. Indeed, the incidence of esophageal adenocarcinoma (EAC) has increased dramatically in the United States[1, 2] as well as most other Western developed societies. The increased incidence is particularly alarming among US white men, which jumped 463% between 1975 and 2004; increases have also been observed in Europe, Australia, and New Zealand. Age-standardized rates of EAC have increased up to 40% every 5 years in England and Wales, while annual increases in incidence rates of up to 5%, 5%, 6%, and 12% have been observed in Scotland, Scandinavia, France, and Switzerland, respectively[1, 3, 5, 6]. EAC has a substantial impact on mortality, with a low 5-year survival rate (16.8%); overall, esophageal cancer has become the eighth most common cause of cancer death worldwide[1, 3]. In contrast to esophageal cancer, the overall incidence rates of colorectal and cervical cancers have declined in the past several decades, but rates of gastric adenocarcinoma have remained relatively stable. Despite these trends, colorectal cancer is still the third most common cancer worldwide, with the highest age-standardized incidence rates in Australia/New Zealand (45.7 per 100,000 men) and Western and Southern Europe (41.2 and 39.3 per 100,000 men, respectively). Colorectal cancer is the third leading cause of cancer mortality in men and women in the United States and accounts for 8% of all cancer deaths worldwide, with the highest mortality rates in Central and Eastern Europe. Cervical cancer is the third most common cancer in women, with an estimated 530,000 new cases worldwide in 2008; incidence and mortality are lower in more developed areas such as Europe and North America than in developing countries in Africa and South America. Gastric cancer is the fourth most common malignancy in the world (989,000 new cases occurring in 2008) and the second leading cause of cancer death (738,000 deaths worldwide), with the highest mortality rates in Eastern Asia and Central and Eastern Europe.
Given the incidence and mortality associated with epithelial cancers, effective strategies for early detection and treatment of premalignant lesions are essential. The benefits of early detection have been clearly demonstrated in cervical cancer, with population-based and cohort studies indicating that regular Pap screenings have decreased cervical cancer incidence and mortality by at least 80%. Similarly, Barrett’s esophagus (BE) has been recognized as the premalignant lesion of EAC[13, 14]. A growing number of studies have shown that regular endoscopic BE surveillance identifies patients with earlier stage cancer[15–17], leading to higher survival rates than more advanced disease. Several retrospective studies have indicated that survival is prolonged if esophageal cancers are detected by endoscopic surveillance rather than by presenting symptoms[13, 15, 18].
This review discusses the substantial progress under way in endoscopic imaging, including the present state of technology, current approaches to imaging research, and the potential impact of these techniques on daily clinical practice in the near future.
Paradigms in endoscopic biopsy: applications and limitations
Current approaches to endoscopic biopsy use external imaging, such as computed tomography (CT), magnetic resonance (MR), or white light endoscopy, to image suspect tissue. Despite advances in the field of endoscopic imaging, technical limitations of these modalities exist. These limitations may have important clinical implications, especially in optimizing cancer screening, diagnosis, and surveillance in the detection and histological assessment of premalignant lesions. For example, treatment guidelines for recognizing EAC and preventing mortality are largely based on endoscopic surveillance of patients with chronic, symptomatic gastroesophageal reflux disease and those with BE as well as use of histopathological assessment to evaluate the risk of BE progression to EAC[13, 14, 19]. Although currently considered the gold standard for surveillance, white light endoscopy is limited to the surface of the mucosa and depends on clinical changes to signify underlying disease. External sources (CT/MR) typically lack sufficient resolution to provide accurate guidance for biopsy location determination.
When BE is identified, targeted biopsies and four-quadrant, random biopsies are obtained to detect invisible neoplasias[14, 19, 20], but these strategies may be unreliable because of sampling error and other practical limitations. When performed appropriately, a random sampling technique reduces the area of tissue surveyed, covering as little as 5% of the surface area of BE tissue. Mucosal irregularities of early neoplasias are often discrete and easily missed during standard BE surveillance endoscopy. In surgical resection specimens, up to 43% of patients with confirmed high-grade dysplasia had adenocarcinomas that were missed before surgery, despite the use of endoscopic biopsy. Given the small amounts of histologically ambiguous tissue retrieved, the potential for diagnostic misinterpretation and variability among pathologists is considerable, a problem that has been demonstrated in several studies[22, 24–26]. The time delay between endoscopy and diagnosis is another limitation, with separate procedures required for the detection and treatment of dysplasia. The current biopsy approach is uncomfortable and time consuming for patients, often requiring a lengthy period of sedation and posing risks of bleeding and perforation[20, 27]. The limitations of current imaging and biopsy methods represent an unmet need in the early detection of mucosal dysplasias.
Current and investigational technologies for in vivo imaging
Comparison of current and investigational imaging technologies
Field of view
Radio nucleotide, DOT, PET
MRI, CT, US
EUS, IVMRI, X-ray
Standard and high-definition video endoscopes
SECM, Micro OCT, FFOCM
Confocal laser endomicroscopy
Confocal laser endomicroscopy (CLE), a recent endoscopic advance, allows real-time high-resolution histologic analysis of targeted tissue during endoscopy. The CLE illuminates tissue with a low-powered laser focused by an objective lens into a single point within a fluorescent specimen[30, 31]. A confocal microscope is used to exclude light above and below a plane of interest, thus allowing for an optical section to be observed, similar to a histologic tissue section. The generated gray scale image represents one focal plane within the examined specimen. The mucosa typically can be imaged to a depth of 100 to 150 μm with this technique.
Although commercially available, the place of CLE in current diagnostic paradigms versus a conventional histopathological examination is still evolving. With appropriate contrast agents, CLE has the potential for subcellular resolution, reducing the number of biopsies required, as well as for molecular characterization. However, available CLE devices have a narrow field of view and cannot penetrate beyond the mucosa, allowing visualization of only superficial mucosal layers[29, 30]. Moreover, CLE does not provide an archive of tissue for full molecular characterization, and contrast agents can limit the procedure duration and ability to obtain repeat images.
Spectrally encoded confocal microscopy
Recent clinical studies have explored a/LCI in the assessment of dysplasia in esophageal and intestinal tissues. In the first in vivo clinical study of a/LCI, 46 patients undergoing routine endoscopic surveillance for BE were scanned with the a/LCI system and the results correlated with an endoscopic biopsy specimen. The nuclear size measurements generated for deep epithelial tissue (200–300 μm beneath the surface) separated dysplastic from non-dysplastic tissue with an accuracy of 86%, using a cutoff of 11.84 μm to separate the two types. Using this same cutoff, a/LCI distinguished dysplastic BE specimens from indeterminate and non-dysplastic BE with a sensitivity of 100% (13/13; 95% confidence interval [CI], 0.75–100) and a specificity of 85% (76/89; 95% CI, 0.76–0.92). Similarly, a pilot ex vivo study of 27 patients undergoing partial colonic resection demonstrated high diagnostic value of this method at a depth 200 to 300 μm beneath the mucosal surface, with a/LCI separating dysplastic from healthy intestinal tissues with a sensitivity of 92.9%, a specificity of 83.6%, and an overall accuracy of 85.2%.
Several other spectroscopy-based imaging techniques are under investigation in various clinical applications. Laser-induced fluorescence is a technique based on the principle that certain compounds exhibit a characteristic fluorescence emission when excited by light. This technology has been shown to detect malignant colonic tissue and to distinguish malignant tissue from metaplastic and normal tissue in BE[56, 58]. Multimodal hyperspectroscopy is based on tissue fluorescence and reflected light measurements, which are analyzed with computed-based algorithms to differentiate between abnormal and normal tissues. Although more extensively explored for use in detecting cervical cancer[59, 60], clinical studies in BE patients are under way.
Optical coherence tomography
OCT is an imaging technique first introduced for use in biological tissues in 1991 that generates high-resolution, cross-sectional, subsurface images by using low-coherence interferometry to measure the echo time delay and intensity of back-scattered light. OCT is analogous to ultrasonography, except that OCT measures the intensity of infrared light rather than sound waves. With OCT, depth intensity is measured by time-domain measurements, allowing for image construction for all three dimensions.
Several OCT systems are currently in use or under investigation. The original OCT technology, now called time-domain OCT (Niris®, Imalux Corporation, Cleveland, OH, USA)[80, 81], has been described in detail elsewhere[64, 78]. Interferometric synthetic aperture microscopy uses computed imaging and synthetic aperture techniques to modify OCT signals to achieve three-dimensional, spatially invariant resolution for all depths in a cross-sectional scan[82–84]. The feasibility of using this technology to image human breast tissue has recently been demonstrated[83, 84].
Despite the diagnostic potential of time-domain OCT, its relatively slow imaging speed has precluded its ability to survey large areas of the GI tract, limiting its use to point-sampling with a field of view comparable to that of conventional biopsy[70, 85]. However, a new technologic approach to OCT allows dramatic increases in imaging speed without compromising image resolution or quality[70, 86–88]. This technology, referred to as Fourier-domain OCT or optical frequency domain imaging, is also called volumetric laser endomicroscopy (VLE). VLE acquires cross-sectional images by using a focused, narrow-diameter beam to repeatedly measure the delay of reflections from within the tissue sample. Interferometry is used to measure the delay intervals, while Fourier transformation is used to compute traditional A-lines, or depth scans, which comprise the tissue reflectivity as a function of depth along the beam. Unlike time-domain OCT, VLE uses a fixed wavelength or swept-source technology in which the wavelength of a monochromatic light source is rapidly scanned to measure the interference signal as a function of wavelength[70, 87].
The use of a balloon-based VLE system with helically scanning optics for esophageal imaging has been described[68–70, 85]. With this system, the optical components of the catheter are positioned with the esophageal lumen via a balloon-centered probe[70, 85]. After the balloon is inflated, the distal esophagus is dilated and the imaging optics become centered. Optics are slowly pulled back during the imaging procedure while the imaging optics are rotated by a probe scanner; thus, the entire portion of the esophageal lumen that was in contact with the balloon is scanned in a helical or circumferential fashion. Real-time, volumetric images are obtained by scanning the imaging beam over the tissue surface in two dimensions.
Roles and impact of the advances in optical biopsy
In vivo pathology imaging devices and the rapid evolution of the technology have the potential to make real-time diagnosis the new standard, with immediate diagnosis and management during endoscopy. The new optical biopsy technologies provide better quality, detailed, high-resolution images and allow visualization of living cells and cellular structures at and below the mucosal surface during ongoing endoscopy[28, 35]. The convergence of imaging and pathology may provide distinct advantages in cancer detection and diagnosis without the limitations and risks inherent with biopsy procedures. With these technologies, maximal diagnostic yields may be obtained, leading to appropriate staging through guided biopsy while minimizing the frequency and error potential of random biopsy protocols. In vivo cellular information can be delivered before biopsies are performed, or imaging files may be transmitted with biopsies, potentially improving the efficiency and accuracy of diagnosis.
Despite the potential these techniques may offer to standard clinical practice, barriers remain. Optical biopsy techniques can identify neoplastic changes in a variety of biologic tissues, but prospective studies in large cohorts are needed to establish concrete sensitivity and specificity of the respective technologies, in each target organ, versus the need for biopsy. To achieve widespread clinical adoption, these technologies must be accurate, efficient for use in the endoscopic setting, reliable, user-friendly, patient-friendly, and cost-effective[22, 89]. Wide acceptance and interpretation capabilities, which require comprehensive physician education and training, are also necessary to establish appropriate comfort with use. Investigators are currently working to improve the accuracy, speed, and ease of interpretation of these technologies. In addition, research is under way to allow real-time data transmission and storage, thereby linking pathology results to the treating physician.
As epithelial malignancies move toward earlier detection and treatment, the ability to accurately detect precancerous lesions has an increasingly important role in controlling cancer incidence and mortality. With new optical techniques, high-resolution images of early neoplastic changes in various tissues and organs can now be captured in real time through endoscopes, catheters, laparoscopes, and needles. Although the diagnostic potential of these technologies is rapidly expanding, their clinical adoption will depend on present and future research demonstrating improved imaging performance and functionality, and the development and acceptance of new guidelines for imaging. Novel optical imaging technology offers the opportunity to utilize a see-and-treat paradigm, potentially leading to improved patient care and cost reduction.
Angle-resolved low-coherence interferometry
Confocal laser endomicroscopy
Endoscope-based confocal laser endomicroscopy
Optical coherence tomography
Probe-based confocal laser endomicroscopy
Spectrally encoded confocal microscopy
Volumetric laser endomicroscopy.
We thank Albert Balkiewicz, MSc, who provided medical writing services through Peloton Advantage, LLC, on behalf of the authors and NinePoint Medical. The authors were fully responsible for the content, editorial decisions, and opinions expressed in the current article. Neither author received an honorarium related to the development of this manuscript.
- Vizcaino AP, Moreno V, Lambert R, Parkin DM: Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973–1995. Int J Canc. 2002, 99 (6): 860-868. 10.1002/ijc.10427.View Article
- Brown LM, Devesa SS, Chow WH: Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Canc Inst. 2008, 100 (16): 1184-1187. 10.1093/jnci/djn211.View Article
- Melhado RE, Alderson D, Tucker O: The changing face of esophageal cancer. Cancers. 2010, 2: 1379-1404. 10.3390/cancers2031379.PubMed CentralView ArticlePubMed
- Lepage C, Rachet B, Jooste V, Faivre J, Coleman MP: Continuing rapid increase in esophageal adenocarcinoma in England and Wales. Am J Gastroenterol. 2008, 103 (11): 2694-2699. 10.1111/j.1572-0241.2008.02191.x.View ArticlePubMed
- Botterweck AA, Schouten LJ, Volovics A, Dorant E, van Den Brandt PA: Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol. 2000, 29 (4): 645-654. 10.1093/ije/29.4.645.View ArticlePubMed
- Falk J, Carstens H, Lundell L, Albertsson M: Incidence of carcinoma of the oesophagus and gastric cardia. Changes over time and geographical differences. Acta Oncol. 2007, 46 (8): 1070-1074. 10.1080/02841860701403046.View ArticlePubMed
- SEER Stat Fact Sheets: Esophagus Cancer. National Cancer Institute Surveillance Epidemiology and End Results. 2011, http://seer.cancer.gov/statfacts/html/esoph.html. Accessed December 5
- Vital signs: colorectal cancer screening, incidence, and mortality--United States, 2002–2010. MMWR Morb Mortal Wkly Rep. 2011, 60 (26): 884-889.
- Trends in age-adjusted SEER incidence rates by cancer site all ages, all races, female 1992–2008 (SEER 13) Cervix Uteri: Trends in age-adjusted SEER incidence rates by cancer site all ages, all races, female 1992–2008 (SEER 13) Cervix Uteri. National Cancer Institute Surveillance Epidemiology and End Results. 2011, http://seer.cancer.gov/faststats/selections.php?#Output. Accessed November 29, 2011
- Schlansky B, Sonnenberg A: Epidemiology of noncardia gastric adenocarcinoma in the United States. Am J Gastroenterol. 2011, 106 (11): 1978-1985. 10.1038/ajg.2011.213.View ArticlePubMed
- Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010, 127 (12): 2893-2917. 10.1002/ijc.25516.View ArticlePubMed
- National Cancer Institute: Cervical cancer screening (PDQ). 2011, http://www.cancer.gov/cancertopics/pdq/screening/cervical/HealthProfessional. Accessed December 5, 2011
- Wang KK, Sampliner RE: Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol. 2008, 103 (3): 788-797. 10.1111/j.1572-0241.2008.01835.x.View ArticlePubMed
- Hirota WK, Zuckerman MJ, Adler DG, Davila RE, Egan J, Leighton JA, Qureshi WA, Rajan E, Fanelli R, Wheeler-Harbaugh J, Baron TH, Faigel DO: ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc. 2006, 63 (4): 570-580. 10.1016/j.gie.2006.02.004.View ArticlePubMed
- Wong T, Tian J, Nagar AB: Barrett's surveillance identifies patients with early esophageal adenocarcinoma. Am J Med. 2010, 123 (5): 462-467. 10.1016/j.amjmed.2009.10.013.View ArticlePubMed
- Portale G, Hagen JA, Peters JH, Chan LS, DeMeester SR, Gandamihardja TA, DeMeester TR: Modern 5-year survival of resectable esophageal adenocarcinoma: single institution experience with 263 patients. J Am Coll Surg. 2006, 202 (4): 588-596. 10.1016/j.jamcollsurg.2005.12.022.View ArticlePubMed
- Rubenstein JH, Sonnenberg A, Davis J, McMahon L, Inadomi JM: Effect of a prior endoscopy on outcomes of esophageal adenocarcinoma among United States veterans. Gastrointest Endosc. 2008, 68 (5): 849-855. 10.1016/j.gie.2008.02.062.PubMed CentralView ArticlePubMed
- van Sandick JW, van Lanschot JJ, Kuiken BW, Tytgat GN, Offerhaus GJ, Obertop H: Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut. 1998, 43 (2): 216-222. 10.1136/gut.43.2.216.PubMed CentralView ArticlePubMed
- Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ: American Gastroenterological Association medical position statement on the management of Barrett's esophagus. Gastroenterology. 2011, 140 (3): 1084-1091.View ArticlePubMed
- Pohl J, Pech O, May A, Manner H, Fissler-Eckhoff A, Ell C: Incidence of macroscopically occult neoplasias in Barrett's esophagus: are random biopsies dispensable in the era of advanced endoscopic imaging?. Am J Gastroenterol. 2010, 105 (11): 2350-2356. 10.1038/ajg.2010.280.View ArticlePubMed
- Canto MI, Kalloo A: Chromoendoscopy for Barrett's esophagus in the twenty-first century: to stain or not to stain?. Gastrointest Endosc. 2006, 64 (2): 200-205. 10.1016/j.gie.2006.03.921.View ArticlePubMed
- Wax A, Terry NG, Dellon ES, Shaheen NJ: Angle-resolved low coherence interferometry for detection of dysplasia in Barrett's esophagus. Gastroenterology. 2011, 141 (2): 443-447. 10.1053/j.gastro.2011.06.020.PubMed CentralView ArticlePubMed
- Heitmiller RF, Redmond M, Hamilton SR: Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. Ann Surg. 1996, 224 (1): 66-71. 10.1097/00000658-199607000-00010.PubMed CentralView ArticlePubMed
- Montgomery E, Bronner MP, Goldblum JR, Greenson JK, Haber MM, Hart J, Lamps LW, Lauwers GY, Lazenby AJ, Lewin DN, Robert ME, Toledano AY, Shyr Y, Washington K: Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol. 2001, 32 (4): 368-378. 10.1053/hupa.2001.23510.View ArticlePubMed
- Reid BJ, Li X, Galipeau PC, Vaughan TL: Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis. Nat Rev Cancer. 2010, 10 (2): 87-101. 10.1038/nrc2773.PubMed CentralView ArticlePubMed
- Terry NG, Zhu Y, Rinehart MT, Brown WJ, Gebhart SC, Bright S, Carretta E, Ziefle CG, Panjehpour M, Galanko J, Madanick RD, Dellon ES, Trembath D, Bennett A, Goldblum JR, Overholt BF, Woosley JT, Shaheen NJ, Wax A: Detection of dysplasia in Barrett's esophagus with in vivo depth-resolved nuclear morphology measurements. Gastroenterology. 2011, 140 (1): 42-50. 10.1053/j.gastro.2010.09.008.PubMed CentralView ArticlePubMed
- Bergman JJ, Tytgat GN: New developments in the endoscopic surveillance of Barrett's oesophagus. Gut. 2005, 54 (Suppl 1): i38-i42.PubMed CentralView ArticlePubMed
- Kiesslich R, Goetz M, Neurath MF: Virtual histology. Best Pract Res Clin Gastroenterol. 2008, 22 (5): 883-897. 10.1016/j.bpg.2008.05.003.View ArticlePubMed
- Paull PE, Hyatt BJ, Wassef W, Fischer AH: Confocal laser endomicroscopy: a primer for pathologists. Arch Pathol Lab Med. 2011, 135 (10): 1343-1348. 10.5858/arpa.2010-0264-RA.View ArticlePubMed
- Kantsevoy SV, Adler DG, Conway JD, Diehl DL, Farraye FA, Kaul V, Kethu SR, Kwon RS, Mamula P, Rodriguez SA, Tierney WM: Confocal laser endomicroscopy. Gastrointest Endosc. 2009, 70 (2): 197-200. 10.1016/j.gie.2009.04.002.View ArticlePubMed
- De Palma GD: Confocal laser endomicroscopy in the "in vivo" histological diagnosis of the gastrointestinal tract. World J Gastroenterol. 2009, 15 (46): 5770-5775. 10.3748/wjg.15.5770.View ArticlePubMed
- Wallace MB, Fockens P: Probe-based confocal laser endomicroscopy. Gastroenterology. 2009, 136 (5): 1509-1513. 10.1053/j.gastro.2009.03.034.View ArticlePubMed
- Goetz M, Kiesslich R: Advanced imaging of the gastrointestinal tract: research vs. clinical tools?. Curr Opin Gastroenterol. 2009, 25 (5): 412-421. 10.1097/MOG.0b013e32832d62c1.View ArticlePubMed
- Becker V, Wallace MB, Fockens P, von Delius S, Woodward TA, Raimondo M, Voermans RP, Meining A: Needle-based confocal endomicroscopy for in vivo histology of intra-abdominal organs: first results in a porcine model (with videos). Gastrointest Endosc. 2010, 71 (7): 1260-1266. 10.1016/j.gie.2010.01.010.View ArticlePubMed
- Kiesslich R, Burg J, Vieth M, Gnaendiger J, Enders M, Delaney P, Polglase A, McLaren W, Janell D, Thomas S, Nafe B, Galle PR, Neurath MF: Confocal laser endoscopy for diagnosing intraepithelial neoplasias and colorectal cancer in vivo. Gastroenterology. 2004, 127 (3): 706-713. 10.1053/j.gastro.2004.06.050.View ArticlePubMed
- De Palma GD: Confocal laser endomicroscopy in the "in vivo" histological diagnosis of the gastrointestinal tract. World J Gastroenterol. 2009, 15 (46): 5770-5775. 10.3748/wjg.15.5770.View ArticlePubMed
- Pohl H, Rosch T, Vieth M, Koch M, Becker V, Anders M, Khalifa AC, Meining A: Miniprobe confocal laser microscopy for the detection of invisible neoplasia in patients with Barrett's oesophagus. Gut. 2008, 57 (12): 1648-1653. 10.1136/gut.2008.157461.View ArticlePubMed
- Kiesslich R, Gossner L, Goetz M, Dahlmann A, Vieth M, Stolte M, Hoffman A, Jung M, Nafe B, Galle PR, Neurath MF: In vivo histology of Barrett's esophagus and associated neoplasia by confocal laser endomicroscopy. Clin Gastroenterol Hepatol. 2006, 4 (8): 979-987. 10.1016/j.cgh.2006.05.010.View ArticlePubMed
- Meining A, Schwendy S, Becker V, Schmid RM, Prinz C: In vivo histopathology of lymphocytic colitis. Gastrointest Endosc. 2007, 66 (2): 398-399. 10.1016/j.gie.2006.12.027.View ArticlePubMed
- Kiesslich R, Hoffman A, Goetz M, Biesterfeld S, Vieth M, Galle PR, Neurath MF: In vivo diagnosis of collagenous colitis by confocal endomicroscopy. Gut. 2006, 55 (4): 591-592. 10.1136/gut.2005.084970.PubMed CentralView ArticlePubMed
- Kitabatake S, Niwa Y, Miyahara R, Ohashi A, Matsuura T, Iguchi Y, Shimoyama Y, Nagasaka T, Maeda O, Ando T, Ohmiya N, Itoh A, Hirooka Y, Goto H: Confocal endomicroscopy for the diagnosis of gastric cancer in vivo. Endoscopy. 2006, 38 (11): 1110-1114. 10.1055/s-2006-944855.View ArticlePubMed
- Liu H, Li YQ, Yu T, Zhao YA, Zhang JP, Zhang JN, Guo YT, Xie XJ, Zhang TG, Desmond PV: Confocal endomicroscopy for in vivo detection of microvascular architecture in normal and malignant lesions of upper gastrointestinal tract. J Gastroenterol Hepatol. 2008, 23 (1): 56-61.PubMed
- Ji R, Li YQ, Gu XM, Yu T, Zuo XL, Zhou CJ: Confocal laser endomicroscopy for diagnosis of Helicobacter pylori infection: a prospective study. J Gastroenterol Hepatol. 2010, 25 (4): 700-705. 10.1111/j.1440-1746.2009.06197.x.View ArticlePubMed
- Venkatesh K, Abou-Taleb A, Cohen M, Evans C, Thomas S, Oliver P, Taylor C, Thomson M: Role of confocal endomicroscopy in the diagnosis of celiac disease. J Pediatr Gastroenterol Nutr. 2010, 51 (3): 274-279.PubMed
- Meining A, Phillip V, Gaa J, Prinz C, Schmid RM: Pancreaticoscopy with miniprobe-based confocal laser-scanning microscopy of an intraductal papillary mucinous neoplasm (with video). Gastrointest Endosc. 2009, 69 (6): 1178-1180. 10.1016/j.gie.2008.06.013.View ArticlePubMed
- Thiberville L, Salaun M, Lachkar S, Dominique S, Moreno-Swirc S, Vever-Bizet C, Bourg-Heckly G: Human in vivo fluorescence microimaging of the alveolar ducts and sacs during bronchoscopy. Eur Respir J. 2009, 33 (5): 974-985. 10.1183/09031936.00083708.View ArticlePubMed
- Sonn GA, Jones SN, Tarin TV, Du CB, Mach KE, Jensen KC, Liao JC: Optical biopsy of human bladder neoplasia with in vivo confocal laser endomicroscopy. J Urol. 2009, 182 (4): 1299-1305. 10.1016/j.juro.2009.06.039.View ArticlePubMed
- Tan J, Quinn MA, Pyman JM, Delaney PM, McLaren WJ: Detection of cervical intraepithelial neoplasia in vivo using confocal endomicroscopy. BJOG. 2009, 116 (12): 1663-1670. 10.1111/j.1471-0528.2009.02261.x.View ArticlePubMed
- Goetz M, Kiesslich R: Advances of endomicroscopy for gastrointestinal physiology and diseases. Am J Physiol Gastrointest Liver Physiol. 2010, 298 (6): G797-G806. 10.1152/ajpgi.00027.2010.View ArticlePubMed
- Kang D, Suter MJ, Boudoux C, Yoo H, Yachimski PS, Puricelli WP, Nishioka NS, Mino-Kenudson M, Lauwers GY, Bouma BE, Tearney GJ: Comprehensive imaging of gastroesophageal biopsy samples by spectrally encoded confocal microscopy. Gastrointest Endosc. 2010, 71 (1): 35-43. 10.1016/j.gie.2009.08.026.PubMed CentralView ArticlePubMed
- Tearney GJ, Webb RH, Bouma BE: Spectrally encoded confocal microscopy. Opt Lett. 1998, 23 (15): 1152-1154. 10.1364/OL.23.001152.View ArticlePubMed
- Kang DK, Suter MJ, Boudoux C, Yachimski PS, Puricelli WP, Nishioka NS, Mino-Kenudson M, Lauwers GY, Bouma BE, Tearney GJ: Co-registered spectrally encoded confocal microscopy and optical frequency domain imaging system. J Microsc. 2010, 239 (2): 87-91.PubMed CentralPubMed
- Boudoux C, Yun S, Oh W, White W, Iftimia N, Shishkov M, Bouma B, Tearney G: Rapid wavelength-swept spectrally encoded confocal microscopy. Opt Express. 2005, 13 (20): 8214-8221. 10.1364/OPEX.13.008214.View ArticlePubMed
- Yoo H, Kang D, Katz AJ, Lauwers GY, Nishioka NS, Yagi Y, Tanpowpong P, Namati J, Bouma BE, Tearney GJ: Reflectance confocal microscopy for the diagnosis of eosinophilic esophagitis: a pilot study conducted on biopsy specimens. Gastrointest Endosc. 2011, 74 (5): 992-1000. 10.1016/j.gie.2011.07.020.PubMed CentralView ArticlePubMed
- Terry N, Zhu Y, Thacker JK, Migaly J, Guy C, Mantyh CR, Wax A: Detection of intestinal dysplasia using angle-resolved low coherence interferometry. J Biomed Opt. 2011, 16 (10): 106002-10.1117/1.3631799.PubMed CentralView ArticlePubMed
- Panjehpour M, Overholt BF, Schmidhammer JL, Farris C, Buckley PF, Vo-Dinh T: Spectroscopic diagnosis of esophageal cancer: new classification model, improved measurement system. Gastrointest Endosc. 1995, 41 (6): 577-581. 10.1016/S0016-5107(95)70194-X.View ArticlePubMed
- Schomacker KT, Frisoli JK, Compton CC, Flotte TJ, Richter JM, Nishioka NS, Deutsch TF: Ultraviolet laser-induced fluorescence of colonic tissue: basic biology and diagnostic potential. Lasers Surg Med. 1992, 12 (1): 63-78. 10.1002/lsm.1900120111.View ArticlePubMed
- von Holstein CS, Nilsson AM, Andersson-Engels S, Willen R, Walther B, Svanberg K: Detection of adenocarcinoma in Barrett's oesophagus by means of laser induced fluorescence. Gut. 1996, 39 (5): 711-716. 10.1136/gut.39.5.711.PubMed CentralView ArticlePubMed
- Ferris DG, Lawhead RA, Dickman ED, Holtzapple N, Miller JA, Grogan S, Bambot S, Agrawal A, Faupel ML: Multimodal hyperspectral imaging for the noninvasive diagnosis of cervical neoplasia. J Low Genit Tract Dis. 2001, 5 (2): 65-72.PubMed
- Ferris DG, Litaker MS, Dickman ED, Allmond LM, Smith KM, Arrington TL: Women's responses to cervical interrogation by fluorescent and reflective spectroscopy. J Low Genit Tract Dis. 2003, 7 (4): 299-303. 10.1097/00128360-200310000-00013.View ArticlePubMed
- Guided Therapeutics: Guided Therapeutics begins human feasibility clinical study for light-based Barrett's esophagus technology jointly developed with Konica Minolta Opto. 2011, Accessed December 5, 2011
- Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, Hee MR, Flotte T, Gregory K, Puliafito CA: Optical coherence tomography. Science. 1991, 254 (5035): 1178-1181. 10.1126/science.1957169.View ArticlePubMed
- Testoni PA: Optical coherence tomography. Sci World J. 2007, 7: 87-108.View Article
- Tearney GJ, Brezinski ME, Bouma BE, Boppart SA, Pitris C, Southern JF, Fujimoto JG: In vivo endoscopic optical biopsy with optical coherence tomography. Science. 1997, 276 (5321): 2037-2039. 10.1126/science.276.5321.2037.View ArticlePubMed
- Hee MR, Puliafito CA, Wong C, Duker JS, Reichel E, Rutledge B, Schuman JS, Swanson EA, Fujimoto JG: Quantitative assessment of macular edema with optical coherence tomography. Arch Ophthalmol. 1995, 113 (8): 1019-1029. 10.1001/archopht.1995.01100080071031.View ArticlePubMed
- Gogas BD, Farooq V, Onuma Y, Magro M, Radu MD, van Geuns RJ, Regar E, Serruys PW: 3-Dimensional optical frequency domain imaging for the evaluation of primary percutaneous coronary intervention in ST-segment elevation myocardial infarction. Int J Cardiol. 2011, 151 (1): 103-105. 10.1016/j.ijcard.2011.06.016.View ArticlePubMed
- Okamura T, Onuma Y, Garcia-Garcia HM, van Geuns RJ, Wykrzykowska JJ, Schultz C, van der Giessen WJ, Ligthart J, Regar E, Serruys PW: First-in-man evaluation of intravascular optical frequency domain imaging (OFDI) of Terumo: a comparison with intravascular ultrasound and quantitative coronary angiography. Euro Intervention. 2011, 6 (9): 1037-1045.PubMed
- Suter MJ, Vakoc BJ, Yachimski PS, Shishkov M, Lauwers GY, Mino-Kenudson M, Bouma BE, Nishioka NS, Tearney GJ: Comprehensive microscopy of the esophagus in human patients with optical frequency domain imaging. Gastrointest Endosc. 2008, 68 (4): 745-753. 10.1016/j.gie.2008.05.014.PubMed CentralView ArticlePubMed
- Suter MJ, Jillella PA, Vakoc BJ, Halpern EF, Mino-Kenudson M, Lauwers GY, Bouma BE, Nishioka NS, Tearney GJ: Image-guided biopsy in the esophagus through comprehensive optical frequency domain imaging and laser marking: a study in living swine. Gastrointest Endosc. 2010, 71 (2): 346-353. 10.1016/j.gie.2009.07.007.PubMed CentralView ArticlePubMed
- Vakoc BJ, Shishko M, Yun SH, Oh WY, Suter MJ, Desjardins AE, Evans JA, Nishioka NS, Tearney GJ, Bouma BE: Comprehensive esophageal microscopy by using optical frequency-domain imaging (with video). Gastrointest Endosc. 2007, 65 (6): 898-905. 10.1016/j.gie.2006.08.009.PubMed CentralView ArticlePubMed
- Evans JA, Bouma BE, Bressner J, Shishkov M, Lauwers GY, Mino-Kenudson M, Nishioka NS, Tearney GJ: Identifying intestinal metaplasia at the squamocolumnar junction by using optical coherence tomography. Gastrointest Endosc. 2007, 65 (1): 50-56. 10.1016/j.gie.2006.04.027.PubMed CentralView ArticlePubMed
- Sivak MV, Kobayashi K, Izatt JA, Rollins AM, Ung-Runyawee R, Chak A, Wong RC, Isenberg GA, Willis J: High-resolution endoscopic imaging of the GI tract using optical coherence tomography. Gastrointest Endosc. 2000, 51 (4 Pt 1): 474-479.View ArticlePubMed
- Poneros JM, Brand S, Bouma BE, Tearney GJ, Compton CC, Nishioka NS: Diagnosis of specialized intestinal metaplasia by optical coherence tomography. Gastroenterology. 2001, 120 (1): 7-12. 10.1053/gast.2001.20911.View ArticlePubMed
- Pfau PR, Sivak MV, Chak A, Kinnard M, Wong RC, Isenberg GA, Izatt JA, Rollins A, Westphal V: Criteria for the diagnosis of dysplasia by endoscopic optical coherence tomography. Gastrointest Endosc. 2003, 58 (2): 196-202. 10.1067/mge.2003.344.View ArticlePubMed
- Testoni PA, Mangiavillano B: Optical coherence tomography in detection of dysplasia and cancer of the gastrointestinal tract and bilio-pancreatic ductal system. World J Gastroenterol. 2008, 14 (42): 6444-6452. 10.3748/wjg.14.6444.PubMed CentralView ArticlePubMed
- Gallwas J, Turk L, Friese K, Dannecker C: Optical coherence tomography as a non-invasive imaging technique for preinvasive and invasive neoplasia of the uterine cervix. Ultrasound Obstet Gynecol. 2010, 36 (5): 624-629. 10.1002/uog.7656.View ArticlePubMed
- Tearney GJ, Brezinski ME, Southern JF, Bouma BE, Boppart SA, Fujimoto JG: Optical biopsy in human urologic tissue using optical coherence tomography. J Urol. 1997, 157 (5): 1915-1919. 10.1016/S0022-5347(01)64900-0.View ArticlePubMed
- Fujimoto JG: Optical coherence tomography for ultrahigh resolution in vivo imaging. Nat Biotechnol. 2003, 21 (11): 1361-1367. 10.1038/nbt892.View ArticlePubMed
- Eloubeidi MA, Provenzale D: Does this patient have Barrett's esophagus? The utility of predicting Barrett's esophagus at the index endoscopy. Am J Gastroenterol. 1999, 94 (4): 937-943. 10.1111/j.1572-0241.1999.990_m.x.View ArticlePubMed
- Imalux Corporation: Niris principles of operation. 2011, http://www.imalux.com/principles.htm. Accessed December 5, 2011
- Bouma BE, Yun SH, Vakoc BJ, Suter MJ, Tearney GJ: Fourier-domain optical coherence tomography: recent advances toward clinical utility. Curr Opin Biotechnol. 2009, 20 (1): 111-118. 10.1016/j.copbio.2009.02.007.PubMed CentralView ArticlePubMed
- Davis BJ, Marks DL, Ralston TS, Carney PS, Boppart SA: Interferometric synthetic aperture microscopy: computed imaging for scanned coherent microscopy. Sensors Basel Sensors. 2008, 8 (6): 3903-3931.View ArticlePubMed
- Ralston TS, Marks DL, Carney PS, Boppart SA: Real-time interferometric synthetic aperture microscopy. Opt Express. 2008, 16 (4): 2555-2569. 10.1364/OE.16.002555.PubMed CentralView ArticlePubMed
- Ralston TS, Marks DL, Carney PS, Boppart SA: Interferometric synthetic aperture microscopy. Nat Phys. 2007, 3: 129-134. 10.1038/nphys514.PubMed CentralView ArticlePubMed
- Yun SH, Tearney GJ, Vakoc BJ, Shishkov M, Oh WY, Desjardins AE, Suter MJ, Chan RC, Evans JA, Jang IK, Nishioka NS, de Boer JF, Bouma BE: Comprehensive volumetric optical microscopy in vivo. Nat Med. 2006, 12 (12): 1429-1433.PubMed CentralView ArticlePubMed
- de Boer JF, Cense B, Park BH, Pierce MC, Tearney GJ, Bouma BE: Improved signal-to-noise ratio in spectral-domain compared with time-domain optical coherence tomography. Opt Lett. 2003, 28 (21): 2067-2069. 10.1364/OL.28.002067.View ArticlePubMed
- Choma M, Sarunic M, Yang C, Izatt J: Sensitivity advantage of swept source and Fourier domain optical coherence tomography. Opt Express. 2003, 11 (18): 2183-2189. 10.1364/OE.11.002183.View ArticlePubMed
- Yun S, Tearney G, Bouma B, Park B, de Boer J: High-speed spectral-domain optical coherence tomography at 1.3 mum wavelength. Opt Express. 2003, 11 (26): 3598-3604. 10.1364/OE.11.003598.PubMed CentralView ArticlePubMed
- Peery AF, Shaheen NJ: Optical coherence tomography in Barrett's esophagus: the road to clinical utility. Gastrointest Endosc. 2010, 71 (2): 231-234. 10.1016/j.gie.2009.09.034.View ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.